DCN Dx to Highlight Lateral Flow Development Services and miniDxR at MEDICA 2024

Barchart · 10/17 07:43

Explore DCN Dx's contract IVD services and customizable lateral flow reader at Booth Hall 3 / D25-2

CARLSBAD, Calif., Oct. 17, 2024 /PRNewswire/ -- DCN Dx, a global leader in contract lateral flow assay (LFA) in vitro diagnostic (IVD) development and manufacturing, and diagnostic clinical research services, will be exhibiting at MEDICA 2024 in Düsseldorf, Germany. Attendees are invited to visit Booth Hall 3 / D25-2 in the US Pavilion to learn about DCN Dx's full range of tailored IVD solutions, including assay development, ISO-compliant manufacturing, and clinical research and regulatory consulting.

Read more at prnewswire.com